New Ru(III) NAMI/NAMI-A Analogue Complexes with Selective Anticancer Activity
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c03490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Manel Estruch-Blasco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, c/Profesor García González, 2, Sevilla41012, Spain. Hauptthemen laut MEDLINE: Antineoplastic Agents, Pyridines, Ruthenium, Dimethyl Sulfoxide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejer?a de Transformaci?n Econ?mica, Industria, Conocimiento y Universidad, Junta de Andaluc?a, MICIU/AEI/10.13039/501100011033.
Abstract (Originalsprache)
NAMI-A (ImH)[trans-RuCl4(dmso-S)(Im)], where dmso-S = sulfur-bonded dimethyl sulfoxide and Im = imidazole emerged as a promising alternative to approved Pt(II) anticancer drugs, offering high antimetastatic activity and low toxicity. However, its development was discontinued due to insufficient activity against primary tumors. In this work, we synthesized 12 new pyridine NAMI derivatives and evaluated their anticancer activity against three cancer cell lines: lung adenocarcinoma A549, melanoma MeWo and bladder cancer T24, and compared with the nonmalignant keratinocyte HaCaT cells. Among them, two complexes exhibited potent cytotoxicity and selectivity while retaining the characteristic antimetastatic activity of the NAMI scaffold. The Ru(III) complex (CHO-PyH)[trans-Ru(CHO-Py)Cl4 (dmso-S)], where CHO-Py = pyridine-3-aldehyde, displayed an IC50 of 34 μM and a selectivity index of 7.60 against A549 cells. Additionally, (NCS-PyH)[trans-RuCl4(dmso-S)(NCS-Py)], where NCS-Py = 3-(isothiocyanatomethyl)pyridine, showed an IC50 of 240 nM and a selectivity index of 5.2 against T24 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, c/Profesor García González, 2, Sevilla41012, Spain.
- Departamento de Farmacología, Facultad de Farmacia, Universidad de Sevilla, c/Profesor García González, 2, Sevilla41012, Spain.
- Instituto de Investigaciones Químicas (IIQ), CSIC-Universidad de Sevilla, avda. Américo Vespucio 49, Sevilla41092, Spain.
- Departamento de Química Física, Facultad de Farmacia, Universidad de Sevilla, c/Profesor García González, 2, Sevilla41012, Spain.
ORCID-Profile: Manel Estruch-Blasco, Eleuterio Álvarez, Antonio Sánchez-Coronilla, Manuel Pernia Leal
Förderung
- Consejer?a de Transformaci?n Econ?mica, Industria, Conocimiento y Universidad, Junta de Andaluc?a
- MICIU/AEI/10.13039/501100011033
Zitieren
APA
Estruch-Blasco, M., Calderón-Montaño, J. M., Álvarez, E., Sánchez-Coronilla, A., López-Lázaro, M., & Pernia Leal, M. (2026). New Ru(III) NAMI/NAMI-A Analogue Complexes with Selective Anticancer Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03490
Vancouver
Estruch-Blasco M, Calderón-Montaño JM, Álvarez E, Sánchez-Coronilla A, López-Lázaro M, Pernia Leal M. New Ru(III) NAMI/NAMI-A Analogue Complexes with Selective Anticancer Activity. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03490
BibTeX
@article{EstruchBlasco2026,
author = {Estruch-Blasco, Manel and Calderón-Montaño, Jose Manuel and Álvarez, Eleuterio and Sánchez-Coronilla, Antonio and López-Lázaro, Miguel and Pernia Leal, Manuel},
title = {New Ru(III) NAMI/NAMI-A Analogue Complexes with Selective Anticancer Activity},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c03490}
}
EUVIMED